Cargando…
Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?
BACKGROUND: Intravenous thrombolytic therapy after ischaemic stroke significantly reduces mortality and morbidity. Actual thrombolysis rates are disappointingly low in many western countries. It has been suggested that higher patient volume is related to shorter door-to-needle-time (DNT) and increas...
Autores principales: | Scherf, S., Limburg, M., Wimmers, R., Middelkoop, I., Lingsma, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839134/ https://www.ncbi.nlm.nih.gov/pubmed/27103535 http://dx.doi.org/10.1186/s12883-016-0574-7 |
Ejemplares similares
-
Bigger is bigger. Better is better
por: Solheim, Ole, et al.
Publicado: (2011) -
Intravenous thrombolysis in the emergency department for the treatment of acute ischaemic stroke
por: Semplicini, A, et al.
Publicado: (2008) -
Variation in Clinical Practice of Intravenous Thrombolysis in Stroke in the Netherlands
por: Bauer, Auke, et al.
Publicado: (2013) -
The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
por: Dong, Qiang, et al.
Publicado: (2017) -
Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020
por: Ye, Qing, et al.
Publicado: (2022)